Sns Financial Group, LLC Pfizer Inc Transaction History

Sns Financial Group, LLC

$978 Million
Q1 2025

A detailed history of Sns Financial Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sns Financial Group, LLC holds 15,646 shares of PFE stock, worth $375,504. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,646

Previous 12,984 20.5%

Holding current value

$375,504

Previous $344,000 15.12%

% of portfolio

0.04%

Previous 0.04%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$25.01 - $27.13 $66,576 - $72,220	2,662 Added 20.5%	15,646 $396,000
Q4 2024 Jan 31, 2025	SELL	$24.8 - $30.19 $28,272 - $34,416	-1,140 Reduced 8.07%	12,984 $344,000
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $162,155 - $183,757	-5,854 Reduced 29.3%	14,124 $408,000
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $909,157 - $1.07 Million	-35,992 Reduced 64.31%	19,978 $558,000
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $67,262 - $77,238	-2,598 Reduced 4.44%	55,970 $1.55 Million
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $24,353 - $31,632	932 Added 1.62%	58,568 $1.69 Million
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $243,595 - $284,738	-7,591 Reduced 11.64%	57,636 $1.91 Million
Q2 2023 Jul 17, 2023	BUY	$36.12 - $41.79 $20,371 - $23,569	564 Added 0.87%	65,227 $2.39 Million
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $588,919 - $766,687	14,951 Added 30.08%	64,663 $2.64 Million
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $616,898 - $805,292	-14,776 Reduced 22.91%	49,712 $0
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $58,857 - $71,849	-1,345 Reduced 2.04%	64,488 $2.82 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $58,348 - $69,183	-1,254 Reduced 1.87%	65,833 $3.45 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1.29 Million - $1.6 Million	28,262 Added 72.79%	67,087 $3.47 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $36,278 - $53,777	-878 Reduced 2.21%	38,825 $2.29 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $2.22 Million - $2.85 Million	-56,486 Reduced 58.72%	39,703 $1.71 Million
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $26,824 - $30,387	-747 Reduced 0.77%	96,189 $3.77 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $43,068 - $48,572	1,286 Added 1.34%	96,936 $3.51 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $5,187 - $6,596	-155 Reduced 0.16%	95,650 $3.52 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $190,849 - $223,909	-6,011 Reduced 5.9%	95,805 $3.52 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $82,799 - $100,448	-2,749 Reduced 2.63%	101,816 $3.33 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $115,796 - $165,448	-4,284 Reduced 3.94%	104,565 $3.41 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $17,710 - $20,099	-538 Reduced 0.49%	108,849 $4.27 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $47,955 - $62,183	-1,476 Reduced 1.33%	109,387 $3.93 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $90,970 - $102,139	-2,460 Reduced 2.17%	110,863 $4.8 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $14,175 - $15,573	378 Added 0.33%	113,323 $4.81 Million
Q4 2018 Feb 05, 2019	BUY	$38.47 - $43.86 $114,178 - $130,176	2,968 Added 2.7%	112,945 $4.93 Million
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $79,522 - $96,455	-2,307 Reduced 2.05%	109,977 $4.85 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $40,994 - $43,703	-1,243 Reduced 1.09%	112,284 $4.07 Million
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $622,245 - $721,890	-19,500 Reduced 14.66%	113,527 $4.03 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $315,471 - $334,725	-9,485 Reduced 6.66%	133,027 $4.82 Million
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $328,569 - $361,955	-10,599 Reduced 6.92%	142,512 $5.09 Million
Q2 2017 Aug 09, 2017	BUY	N/A	153,111	153,111 $5.14 Million

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $135B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Account

Sns Financial Group, LLC Pfizer Inc Transaction History